XML 51 R34.htm IDEA: XBRL DOCUMENT v3.23.3
DEBT (Tables)
12 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt
Long term debt as of September 30, 2023 and September 30, 2022 is detailed in the table below.
September 30, 2023September 30, 2022
Seller Note – Bolder BioPath (Related party)602 808 
Seller Note – Preclinical Research Services541 615 
Seller Note – Plato BioPharma— 1,470 
Seller Payable - Orient BioResource Center3,649 3,488 
Seller Note – Histion (Related party)229 369 
Seller Note – Protypia (Related party)400 600 
Economic Injury Disaster Loan140 140 
Convertible Senior Notes110,651 104,965 
Term Loan Facility, DDTL and Incremental Term Loans272,930 238,200 
389,142 350,655 
Less: Current portion(7,950)(7,979)
Less: Debt issuance costs not amortized(11,397)(11,999)
Total Long-term debt$369,795 $330,677 
Schedule of Maturities of Long-Term Debt
The following table summarizes the amount of maturities of our long-term debt for each of the next five fiscal years and thereafter:
20242025202620272028ThereafterTotal
Long-term debt$7,953 $3,541 $2,917 $263,951 $110,654 $126 $389,142